Michael Deininger Email & Phone Number

I am a physician-scientist with a research is focused on myeloid malignancies, specifically aberrant signaling, targeted therapy, and drug resistance. I completed medical school and training in Internal Medicine and Hematology/Oncology in Germany, followed a PhD in leukemia biology at Imperial College, London. In 2002 I was recruited to Oregon Health & Science University and in 2007 became Head of Hematologic Malignancies and Program Leader at Knight Cancer Institute. In 2010 I was recruited to the University of Utah to become Division Chief for Hematology and Hematologic Malignancies, Senior Director for Transdisciplinary Research at Huntsman Cancer Institute, and M.M. Wintrobe Professor of Medicine. In 2021 I joined the Versiti Blood Research Institute as Director and Senior Investigator, and the Medical College of Wisconsin as a Professor of Medicine. My research spans the entire spectrum of myeloid malignancies. In my frame of thinking, leukemogenesis is a process unfolding in an ecosystem populated by both malignant and non-malignant cells that interact with each other and their acellular environment, creating dependencies that can be exploited therapeutically. I have led an NIH-funded lab almost 20 years, served as PI on numerous clinical trials, and published more than 300 peer-reviewed manuscripts.